Efficacy of ivermectin treatment on disease progression among adults with mild to moderate COVID-19 and comorbidities: the I-TECH randomized clinical trial
…, SK Chidambaram, KM Peariasamy… - JAMA internal …, 2022 - jamanetwork.com
Importance Ivermectin, an inexpensive and widely available antiparasitic drug, is prescribed
to treat COVID-19. Evidence-based data to recommend either for or against the use of …
to treat COVID-19. Evidence-based data to recommend either for or against the use of …
[HTML][HTML] Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study
…, MD Pathmanathan, KM Peariasamy… - The Lancet Regional …, 2020 - thelancet.com
Background COVID-19 emerged as a major public health outbreak in late 2019. Malaysia
reported its first imported case on 25th January 2020, and adopted a policy of extensive …
reported its first imported case on 25th January 2020, and adopted a policy of extensive …
[HTML][HTML] Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study
…, FM Zin, SM Zin, H Yahaya, KM Peariasamy… - International Journal of …, 2022 - Elsevier
Objectives We aimed to investigate and compare waning vaccine effectiveness (VE) against
COVID-19 infection, COVID-19 related ICU admission, and COVID-19-related death for …
COVID-19 infection, COVID-19 related ICU admission, and COVID-19-related death for …
[HTML][HTML] Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis
…, DKF Ying, MAA Rahman, KM Peariasamy… - The Lancet Digital …, 2022 - thelancet.com
Background Telemedicine has been increasingly integrated into chronic disease management
through remote patient monitoring and consultation, particularly during the COVID-19 …
through remote patient monitoring and consultation, particularly during the COVID-19 …
[HTML][HTML] Influence of population density for COVID-19 spread in Malaysia: an ecological study
…, MFA Jamil, ASH Ch'ng, I Looi, KM Peariasamy - International journal of …, 2021 - mdpi.com
The rapid transmission of highly contagious infectious diseases within communities can yield
potential hotspots or clusters across geographies. For COVID-19, the impact of population …
potential hotspots or clusters across geographies. For COVID-19, the impact of population …
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 …
…, T Thevananthan, KM Peariasamy… - Emerging microbes & …, 2022 - Taylor & Francis
Given emerging evidence of immune escape in the SARS-CoV-2 Omicron viral variant, and
its dominance, effectiveness of heterologous and homologous boosting schedules …
its dominance, effectiveness of heterologous and homologous boosting schedules …
[HTML][HTML] Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory …
…, TS Tuan Soh, A Haji Hassan, KM Peariasamy… - PLoS …, 2021 - journals.plos.org
Rapid diagnosis is an important intervention in managing the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) outbreak. Real time reverse transcription polymerase …
Syndrome Coronavirus 2 (SARS-CoV-2) outbreak. Real time reverse transcription polymerase …
[HTML][HTML] Tracking the early depleting transmission dynamics of COVID-19 with a time-varying SIR model
The susceptible-infectious-removed (SIR) model offers the simplest framework to study
transmission dynamics of COVID-19, however, it does not factor in its early depleting trend …
transmission dynamics of COVID-19, however, it does not factor in its early depleting trend …
[HTML][HTML] PICK-ing Malaysia's epidemic apart: effectiveness of a diverse COVID-19 vaccine portfolio
…, H Mohd Ibrahim, NH Abdullah, KM Peariasamy - Vaccines, 2021 - mdpi.com
Malaysia rolled out a diverse portfolio of predominantly three COVID-19 vaccines (AZD1222,
BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine …
BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine …
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study
…, F Mahmud, S Sivasampu, KM Peariasamy… - Vaccine, 2022 - Elsevier
Background Rapid deployment of COVID-19 vaccines is challenging for safety surveillance,
especially on adverse events of special interest (AESIs) that were not identified during the …
especially on adverse events of special interest (AESIs) that were not identified during the …